Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies

BACKGROUND: The PROTECT‐AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protection in Patients With Atrial Fibrillation) and PREVAIL (Evaluation of the Watchman LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy) trials demonstrated noninferio...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouwer, Tom F., Whang, William, Kuroki, Kenji, Halperin, Jonathan L., Reddy, Vivek Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912972/
https://www.ncbi.nlm.nih.gov/pubmed/31752643
http://dx.doi.org/10.1161/JAHA.119.013525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912972/
https://www.ncbi.nlm.nih.gov/pubmed/31752643
http://dx.doi.org/10.1161/JAHA.119.013525

Ejemplares similares